Latest press releases

14-Nov-24

Convatec responds to Local Coverage Determinations (LCDs) on skin substitutes

12-Nov-24

Trading update for the ten months ended 31 October 2024

21-Oct-24

Convatec collaborates with AbbVie for VYALEV™ therapy for the treatment of advanced Parkinson’s disease in the United States

10-Oct-24

Convatec update on InnovaMatrix® AC clinical data – second randomised controlled trial authorised

20-Sep-24

Convatec update on InnovaMatrix® AC clinical data

21-Aug-24

Comment on the announcement of CMS changes to catheter codes

01-Aug-24

Convatec me+ Companion™ App offers support for millions of intermittent catheter users

30-Jul-24

Interim Results for the six months ended 30 June 2024

26-Jul-24

Convatec’s pioneering catheter for women continues to scale up in Europe

16-May-24

AGM trading update for the four months ended 30 April 2024

01-May-24

Convatec unveils significant advanced wound care clinical study results

26-Apr-24

Comment on proposed draft Local Coverage Determinations (LCDs) on skin substitutes

06-Mar-24

Annual Results for the twelve months ended 31 December 2023

29-Feb-24

Convatec launches new Esteem Body™ with Leak Defense™

11-Jan-24

Convatec expands support for people living with advanced Parkinson´s disease

14-Nov-23

Trading update for the ten months ended 31 October 2023